[1]
|
Neilson, L.E., Rogers, L.R. and Sundararajan, S. (2019) Evaluation and Treatment of a Patient with Recurrent Stroke in the Setting of Active Malignancy. Stroke, 50, e9-e11. https://doi.org/10.1161/STROKEAHA.118.022088
|
[2]
|
Ito, S., Kikuchi, K., Ueda, A., et al. (2018) Changes in Serial D-Dimer Levels Predict the Prognoses of Trousseau’s Syndrome Patients. Frontiers in Neurology, 9, 528. https://doi.org/10.3389/fneur.2018.00528
|
[3]
|
张艳召, 汪凯, 张辉, 等. 以急性脑梗死为首发表现的隐匿性恶性肿瘤患者13例临床特点总结[J]. 国际神经病学神经外科学杂志, 2017, 44(1): 58-62.
|
[4]
|
Jeon, Y., Baik, S.H., Jung, C., et al. (2021) Mechanical Thrombectomy in Patients with Acute Cancer-Related Stroke: Is the Stent Retriever Alone Effective? Journal of Neurointerventional Surgery, 13, 318-323.
|
[5]
|
张静, 赵静霞. 癌症患者的缺血性卒中: 病理生理学和治疗[J]. 国际脑血管病杂志, 2019, 27(11): 871-876.
|
[6]
|
王誉然, 米小昆, 张静, 等. 癌症患者化疗与卒中[J]. 国际脑血管病杂志, 2022, 30(1): 42-47.
|
[7]
|
Ikushima, S., Ono, R., Fukuda, K., et al. (2016) Trousseau’s Syndrome: Cancer-Associated Thrombosis. Japanese Journal of Clinical Oncology, 46, 204-208. https://doi.org/10.1093/jjco/hyv165
|
[8]
|
Dammacco, F., Vacca, A., Procaccio, P., et al. (2013) Cancer-Related Coagulopathy (Trousseau’s Syndrome): Review of the Literature and Experience of a Single Center of Internal Medicine. Clinical & Experimental Medicine, 13, 85-97.
https://doi.org/10.1007/s10238-013-0230-0
|
[9]
|
Ling, Y., Li, Y., Zhang, X., et al. (2022) Clinical Features of Trousseau’s Syndrome with Multiple Acute Ischemic Strokes. Neurological Sciences, 43, 2405-2411. https://doi.org/10.1007/s10072-021-05619-y
|
[10]
|
Tsushima, M., Metoki, N., Hagii, J., et al. (2019) D-Dimer and C-Reactive Protein as Potential Biomarkers for Diagnosis of Trousseau’s Syndrome in Patients with Cerebral Embolism. Journal of Stroke and Cerebrovascular Diseases, 29, Article ID: 104534. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104534
|
[11]
|
王继蕊, 林梅青, 赵久晗, 等. 合并恶性肿瘤的脑梗死的临床特点及影响预后的相关因素分析[J]. 中国卒中杂志, 2021, 16(2): 136-140.
|
[12]
|
Cheng, Y., Ning, Y., Zhao, Y., et al. (2023) Association between Three-Territory Sign and Prognosis of Acute Ischemic Stroke Patients with Malignancy. Frontiers in Neurology, 14, Article ID: 1265715.
https://doi.org/10.3389/fneur.2023.1265715
|
[13]
|
Wang, Z., Miao, J., Wang, L., et al. (2021) EGFR-Mutant NSCLC Presenting with Stroke and Massive Systemic Embolization as the First Manifestation: Case Report. BMC Neurology, 21, Article Number: 221.
https://doi.org/10.1186/s12883-021-02236-2
|
[14]
|
Hedvat, J., Howlett, C., Mccloskey, J.K., et al. (2016) Evalua-tion of Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in the Oncology Population. Blood, 128, 5026.
https://doi.org/10.1182/blood.V128.22.5026.5026
|
[15]
|
Key, N.S., Khorana, A.A., Kuderer, N.M., et al. (2020) Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology, 38, 496-520.
|
[16]
|
Franco-Moreno, A., Cabezón-Gutiérrez, L., Palka-Kotlowsa, M., et al. (2019) Evaluation of Direct Oral Anticoagulants for the Treatment of Cancer-Associated Thrombosis: An Update. Journal of Thrombosis and Thrombolysis, 47, 409-419. https://doi.org/10.1007/s11239-018-1783-2
|
[17]
|
Rak, J., et al. (2006) Oncogenes, Trousseau Syndrome, and Cancer-Related Changes in the Coagulome of Mice and Humans. Cancer Research, 66, 10643-10646.
|
[18]
|
Fujimoto, M., Ishitsuka, Y., Tanemura, A., et al. (2023) Trousseau Syndrome in a Case of Extramammary Paget’s Disease. Acta Dermato-Venereologica, 103, adv9405. https://doi.org/10.2340/actadv.v103.9405
|